'Picture Quiz Answers: A severe rash

Area of Science:

• Dermatology
• Pharmacology
• Internal Medicine

Background:

• Stevens-Johnson Syndrome (SJS) is a severe mucocutaneous adverse drug reaction.
• Sulfasalazine is a medication used for inflammatory conditions.
• Prompt identification and withdrawal of the offending agent are crucial in managing SJS.

Purpose of the Study:

• To report a case of Stevens-Johnson Syndrome.
• To highlight the potential link between sulfasalazine and SJS.
• To describe the management and outcome of SJS.

Main Methods:

• Clinical diagnosis of Stevens-Johnson Syndrome.
• Discontinuation of sulfasalazine.
• Treatment with oral corticosteroids (prednisolone).
• Clinical monitoring and follow-up.

Main Results:

• The patient was diagnosed with Stevens-Johnson Syndrome.
• Sulfasalazine was identified as the probable causative agent and was discontinued.
• Treatment with oral prednisolone resulted in significant improvement.
• Rash resolved and fever subsided within a week of treatment initiation.

Conclusions:

• Sulfasalazine can precipitate Stevens-Johnson Syndrome.
• Early diagnosis and corticosteroid treatment are effective in managing SJS.
• Multidisciplinary care involving dermatology and rheumatology ensures optimal patient outcomes.